ASCO 2023

Share

Program Content

Activities

  • Slides: Key Data From ASCO 2023
    Slides: Expert Insight Key Data From ASCO 2023 Informing Treatment for Endometrial, Cervical, and Ovarian Cancers
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 13, 2023

  • Key Data From ASCO 2023
    Expert Insight on Key Updates and New Clinical Trial Data From the 2023 ASCO Annual Meeting, Informing Treatment for Cervical, Ovarian, and Endometrial Cancers
    Conference Coverage
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 22, 2023

  • ASCO: Key Gyn Data
    Expert Commentary and Insight on Key Data From the 2023 ASCO Annual Meeting Informing Treatment for Endometrial, Cervical, and Ovarian Cancers
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 29, 2023

Faculty

cover img faculity

Nicoletta Colombo, MD, PhD

Associate Professor of Obsterics and Gynecology
European Institute of Oncology 
University of Milan-Bicocca
Milan, Italy  

cover img faculity

Kathleen N Moore, MD, MS

Virginia Kerley Cade Chair in Developmental Therapeutics
Deputy Director
Cancer Therapeutics Co-Director
Stephenson Cancer Center at the University of Oklahoma
ASCO BOD
Oklahoma City, Oklahoma

Provided by

ProCE Banner

Supporters

This educational activity is supported by educational grants from AstraZeneca, GlaxoSmithKline, Merck Sharp & Dohme Corp, Novocure, Genmab and Seagen.

AstraZeneca

Genmab

GlaxoSmithKline

Merck Sharp & Dohme Corp.

Novocure

Seagen